Builders FirstSource Inc. (BLDR): Today's Featured Retail Loser

The retail industry closed the day down 2.2%. Charming Shoppes Inc ( CHRS), ValueVision Media Inc ( VVTV), Talbots Inc ( TLB), and Conn's Inc ( CONN) were all decliners today within the retail industry with Builders FirstSource Inc ( BLDR) being today's featured retail loser. Builders FirstSource Inc fell 11 cents (-8%) to $1.27 on light volume. Throughout the day, 17,849 shares of Builders FirstSource Inc exchanged hands as compared to its average daily volume of 139,000 shares.

Builders FirstSource, Inc. engages in the manufacture and supply of structural and related building products for residential new construction primarily in the southern and eastern United States. Builders FirstSource Inc has a market cap of $134.5 million and is part of the services sector. Shares are down 29.4% year to date as of the close of trading on Thursday.

TheStreet Ratings rates Builders FirstSource as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow, poor profit margins, generally disappointing historical performance in the stock itself and generally weak debt management.

On the positive front, Bidz.com Inc ( BIDZ), Haverty Furniture Companies CL A ( HVT.A), Pacific Sunwear ( PSUN), and China Jo-Jo Drugstores Inc ( CJJD) were all gainers within the retail industry with Walgreen Company ( WAG) being today's featured retail industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the retail industry could consider SPDR S&P Retail ETF ( XRT) while those bearish on the retail industry could consider ProShares Ultra Sht Consumer Goods ( SZK).

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing